The aims of the present study were (a) to compare the expression level of SELENBP1 in the tumor with that in normal adjacent tissue, and (b) to define the value of SELENBP1 expression for predicting tumor outcomes, such as progression and cancer-related death. Here, SELENBP1 is linked to cancer.